[ Price : $8.95]
FDA approves a Genmab supplemental BLA for the use of Arzerra (ofatumumab) in combination with fludarabine and cyclophosphamide fo...[ Price : $8.95]
An Alabama federal court approves a Sandoz motion to dismiss claims against it alleging improper warnings about the risks of amiod...[ Price : $8.95]
Attorney Bradley Davidsen says a new FDA draft guidance on safety updates to some generic drug labels raises hope that the agency ...[ Price : $8.95]
FDA plans a two-day public hearing in November to obtain input on off-label communication by drug and medical device companies.[ Price : $8.95]
FDA denies a petition asking it to place a clinical hold on an extracorporeal liver assist device reportedly being developed by Vi...[ Price : $8.95]
FDA requires labeling changes to many opioids and benzodiazepines warning about adverse risks of using them together.[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance: Submission of Warning Plans for Cigars.[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Bloo...